Commensal-pathogen dynamics structure disease outcomes during Clostridioides difficile colonization
- PMID: 39731916
- PMCID: PMC11717617
- DOI: 10.1016/j.chom.2024.12.002
Commensal-pathogen dynamics structure disease outcomes during Clostridioides difficile colonization
Abstract
Gastrointestinal colonization by Clostridioides difficile is common in healthcare settings and ranges in presentation from asymptomatic carriage to lethal C. difficile infection (CDI). We used a systems biology approach to investigate why patients colonized with C. difficile have a range of clinical outcomes. Microbiota humanization of germ-free mice with fecal samples from toxigenic C. difficile carriers revealed a spectrum of virulence among clinically prevalent clade 1 lineages and identified candidate taxa, including Blautia, as markers of stable colonization. Using gnotobiotic mice engrafted with defined human microbiota, we validated strain-specific CDI severity across clade 1 strains isolated from patients. Mice engrafted with a community broadly representative of colonized patients were protected from severe disease across all strains without suppression of C. difficile colonization. These results underline the capacity of gut community structure to attenuate a diversity of pathogenic strains without inhibiting colonization, providing insight into determinants of stable C. difficile carriage.
Keywords: Clostridioides difficile; gastrointestinal infection; gut microbiome.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests E.R.D. has served as a consultant for Seres Therapeutics, Ferring Pharmaceuticals, AstraZeneca, Summit, Merck, Recursion, and Abbott and has received research support from Theriva Biologics, Ferring Pharmaceuticals, and Pfizer, all unrelated to this study.
Update of
-
Commensal-pathogen dynamics structure disease outcomes during Clostridioides difficile colonization.bioRxiv [Preprint]. 2024 Jul 30:2024.07.11.603094. doi: 10.1101/2024.07.11.603094. bioRxiv. 2024. Update in: Cell Host Microbe. 2025 Jan 8;33(1):30-41.e6. doi: 10.1016/j.chom.2024.12.002. PMID: 39026847 Free PMC article. Updated. Preprint.
Similar articles
-
Commensal-pathogen dynamics structure disease outcomes during Clostridioides difficile colonization.bioRxiv [Preprint]. 2024 Jul 30:2024.07.11.603094. doi: 10.1101/2024.07.11.603094. bioRxiv. 2024. Update in: Cell Host Microbe. 2025 Jan 8;33(1):30-41.e6. doi: 10.1016/j.chom.2024.12.002. PMID: 39026847 Free PMC article. Updated. Preprint.
-
Multi-omics investigation of Clostridioides difficile-colonized patients reveals pathogen and commensal correlates of C. difficile pathogenesis.Elife. 2022 Jan 27;11:e72801. doi: 10.7554/eLife.72801. Elife. 2022. PMID: 35083969 Free PMC article.
-
Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.mBio. 2022 Aug 30;13(4):e0136422. doi: 10.1128/mbio.01364-22. Epub 2022 Aug 1. mBio. 2022. PMID: 35913161 Free PMC article.
-
Clostridioides difficile and Gut Microbiota: From Colonization to Infection and Treatment.Pathogens. 2024 Jul 31;13(8):646. doi: 10.3390/pathogens13080646. Pathogens. 2024. PMID: 39204246 Free PMC article. Review.
-
The role of the gut microbiome in colonization resistance and recurrent Clostridioides difficile infection.Therap Adv Gastroenterol. 2022 Nov 18;15:17562848221134396. doi: 10.1177/17562848221134396. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 36425405 Free PMC article. Review.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases